By Associate Professor Suzanne Jean Hodgkinson

Preprints

De Brouwer E; Becker T; Werthen-Brabants L; Dewulf P; Iliadis D; Dekeyser C; Laureys G; Van Wijmeersch B; Popescu V; Dhaene T; Deschrijver D; Waegeman W; De Baets B; Stock M; Horakova D; Patti F; Izquierdo G; Eichau S; Girard M; Prat A; Lugaresi A; Grammond P; Kalincik T; Alroughani R; Grand’Maison F; Skibina O; Terzi M; Lechner-Scott J; Gerlach O; Khoury SJ; Cartechini E; Van Pesch V; Sa MJ; Weinstock-Guttman B; Blanco Y; Ampapa R; Spitaleri D; Solaro C; Maimone D; Soysal A; Iuliano G; Gouider R; Castillo-Triviño T; Sanchez-Menoyo JL; Laureys G; van der Walt A; Oh J; Aguera-Morales E; Altintas A; Al-Asmi A; de Gans K; Fragoso Y; Csepany T; Hodgkinson S; Deri N; Al-Harbi T; Taylor B; Gray O; Lalive P; Rozsa C; McGuigan C; Kermode A; Perez sempere A; Mihaela S; Simo M; Hardy T; Decoo D; Hughes S; Grigoriadis N; Sas A; Vella N; Moreau Y; Peeters L, 2022, Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study, http://dx.doi.org/10.1101/2022.09.08.22279617

Maltby VE; Lea RA; Monif M; Fabis-Pedrini MJ; Buzzard K; Kalincik T; Kermode AG; Taylor B; Hodgkinson S; McCombe P; Butzkueven H; Barnett M; Lechner-Scott J, 2020, Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study) (Preprint), http://dx.doi.org/10.2196/preprints.24969

Kalincik T; Sharmin S; Malpas C; Spelman T; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Jokubaitis V; van der Walt A; Grand’Maison F; Sola P; Ferraro D; Shaygannejad V; Alroughani R; Hupperts R; Terzi M; Boz C; Lechner-Scott J; Pucci E; Van Pesch V; Granella F; Bergamaschi R; Spitaleri D; Slee M; Vucic S; Ampapa R; McCombe P; Ramo-Tello C; Prevost J; Olascoaga J; Cristiano E; Barnett M; Saladino ML; Sanchez-Menoyo JL; Hodgkinson S; Rozsa C; Hughes S; Moore F; Shaw C; Butler E; Skibina O; Gray O; Kermode A; Csepany T; Singhal B; Shuey N; Piroska I; Taylor B; Simo M; Sirbu C-A; Sas A; Butzkueven H, 2019, Immunotherapy prevents long-term disability in relapsing multiple sclerosis over 15 years, http://dx.doi.org/10.1101/735662

Back to profile page